Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.
about
Aerosolised antibiotics for the management of healthcare-associated pneumonia (HCAP) and ventilator-associated pneumonia (VAP)Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsChest physiotherapy for pneumonia in childrenChest physiotherapy for pneumonia in childrenShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsKlebsiella pneumoniae: Going on the Offense with a Strong DefensePrevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative reviewCurrent and Future Considerations for the Treatment of Hospital-Acquired PneumoniaImplementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic dataAccuracy of using automated methods for detecting adverse events from electronic health record data: a research protocol.Identifying missed opportunities to curtail antimicrobial therapy for presumed ventilator-associated pneumonia using the clinical pulmonary infection score.Impact of four sequential measures on the prevention of ventilator-associated pneumonia in cardiac surgery patients.Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study.Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.Molecular detection of Candida spp. and Aspergillus fumigatus in bronchoalveolar lavage fluid of patients with ventilator-associated pneumoniaEarly-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment.A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.A national survey of the diagnosis and management of suspected ventilator-associated pneumonia.Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae.Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitalsGuideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy.Duration of hospital admission and the need for empirical antipseudomonal therapy.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa.Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Review on the Antimicrobial Resistance of Pathogens from Tracheal and Endotracheal Aspirates of Patients with Clinical Manifestations of Pneumonia in Bacolod City in 2013Postoperative biological and clinical outcomes following uncomplicated pancreaticoduodenectomyA systematic review and meta-analysis of perioperative oral decontamination in patients undergoing major elective surgery.Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains.A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.Inpatient treatment of community-acquired pneumonias with integrative medicine.Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.A Preoperative Risk Model for Postoperative Pneumonia After Coronary Artery Bypass GraftingFace and/or neck burns: a risk factor for respiratory infection?Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis.Audit and Feedback-Focused approach to Evidence-based Care in Treating patients with pneumonia in hospital (AFFECT Study).Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.Nasal-Swab Results for Methicillin-Resistant Staphylococcus aureus and Associated InfectionsAntibiotic Utilization Patterns in Patients with Ventilator-Associated Pneumonia: A Canadian Context.
P2860
Q24187516-13145F72-CBDD-405C-8485-CB0DE1A9CD70Q24187768-D7AB715B-4A3D-4396-969E-2D50D0F5A715Q24198047-2F24D91C-75BA-4CFC-B674-018D89BD9852Q24202754-CF7A08F6-E38E-47E4-9DA5-D070A010E322Q24236108-E455D8BE-B0DD-4287-9759-BE55D32B21FDQ26745802-A4FC0051-A5B0-420A-A0BB-221FC6BE0F1EQ28069165-54D54C02-54DE-41DD-93AD-5217D768D552Q28071882-CEDC310A-A6F5-45CE-B326-FBD687707CABQ30848185-5152662E-46E5-44B6-8EB6-AA2A8AAE2DCBQ30883204-EAA9F27F-16AA-49E6-ACDE-C6DC44899640Q33681164-CAC96021-6FCA-46AA-829C-1D215304EA87Q33752655-CD9201F4-F4B4-4091-A5EA-7891316D74D7Q33821913-647C38B7-44F0-4A14-9949-F69B1111B02BQ33824063-8936D8E8-7D38-4634-9A0A-B02A35BA7F3BQ33833257-1CEF392A-BDB5-4954-9FCC-E495163B6ABAQ34404666-482E5C8B-9F0E-468E-9544-9AAAFBE98A61Q34611874-CC617FE3-976F-4DE3-BA14-ABB49F16FC71Q34767855-DAC1AF62-2AC1-4E7D-8B36-C13465A2D56CQ35005044-AC1B5608-4A31-4735-BE48-0403D58330D9Q35385445-38F99751-BAAF-4781-986F-C7F6618E2421Q35569189-C987398B-E2CD-47B2-803A-EE9BA1452120Q35959224-9DFF7142-7B99-45F7-9D7E-4C7B827B6204Q36171313-2C2686DD-1709-492D-A2AA-B5656B355EF2Q36281234-F7150B16-A6FA-4E8A-9E30-1B5A46008D40Q36396244-993BFF31-AE2A-447D-B780-37CBE51E66E6Q36517624-80344780-DF73-420F-BDE5-CAEDBD85414FQ36556699-C009857C-260B-4B38-BAEB-11A94CDB41D2Q36618342-E87B6255-6431-45FC-9396-3D0EA0756290Q36714279-974F980B-1FBC-422D-88D5-AFD81AB21B72Q36881585-C4E87B36-9C20-405B-A2B4-8CED58E32819Q36902744-C3D50105-815B-49B1-BE42-72D0CAA53C70Q36907878-D026BD98-96A5-4170-8308-971F838D1762Q36969982-47F31C6F-285C-4458-B27D-F74F842B115FQ37270501-B0D7DEC9-4013-4C94-8706-D71C544FAB2AQ37618869-77F61958-6226-4CB6-AA53-0CE4A985788BQ37713661-7D70A932-014E-41C2-BF7A-4C909DCB2F4AQ38196395-4CB3DBB7-C2F3-4EB4-9002-735B09216FBDQ38790132-D755D4A4-C1BF-4EC1-848A-6EB825050FBFQ39294431-F2CFB900-75CF-4635-847E-781744B6DC53Q39490026-AC56020C-3541-49FD-8C04-FC025A448918
P2860
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@en
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@nl
type
label
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@en
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@nl
prefLabel
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@en
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@nl
P2093
P2860
P356
P1476
Clinical practice guidelines f ...... ssociated pneumonia in adults.
@en
P2093
Abraham Born
Barrie McTaggart
Coleman Rotstein
Karl Weiss
R Bruce Light
Ronald Grossman
Sheldon Magder
P2860
P356
10.1155/2008/593289
P407
P577
2008-01-01T00:00:00Z